Recombinant Tafazzin (TAZ)

• Product Name Alternative:

  CMD3A; EFE2; EFE; BTHS; XAP-2; G4.5; Barth syndrome; Endocardial Fibroelastosis 2; Cardiomyopathy, Dilated 3A (X-Linked)

• Synonyms:

  Tafazzin

• CAS Number:

  9000-83-3

• UniProt:

  Q4KLG6

• Expression System:

  Prokaryotic expression

• Host:

  E. coli

• Tag:

  N-terminal His Tag

• Source:

  Prokaryotic expression

• Applications:

  Positive Control; Immunogen; SDS-PAGE; WB.

• Field of Research:

  Cardiovascular biology

• Endotoxin:

  < 1.0 EU per 1 µg (determined by the LAL method)

• Purity:

  > 97%

• Form:

  Freeze-Dried Powder

• Buffer:

  20 mM Tris, 150 mM NaCl, pH8.0, containing 1mM EDTA, 1mM DTT, 0.01% SKL, 5% Trehalose and Proclin300.

• Calculated Molecular Weight:

  26.1 KDa

• Observed Molecular Weight:

  27kDa

• Fragment:

  Asn46~Phe239

• Isoelectric Point:

  9

• Subcellular Location:

  Membrane

• Organism Species:

  Rattus norvegicus (Rat)